Pharma Focus Asia

Local Production Of Pharmaceuticals And Related Technology Transfer In Developing Countries

Abstract:

As stakeholders in the Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property (GSPA-PHI) adopted by the World Health Assembly in 2008,1 the United Nations Conference on Trade and Development (UNCTAD), the World Health Organization (WHO) and the International Centre for Trade and Sustainable Development (ICTSD) are collaborating on a project funded by the European Union (EU) to identify the main challenges and obstacles to local production in developing countries, with particular reference to technology transfer issues, and providing evidence- based recommendations on their feasibility and sustainability. As part of its contribution to this project, UNCTAD was responsible for undertaking this series of case studies designed to examine the transfer of technology and local production of pharmaceuticals in different regions, highlighting different characteristics such as firm structure, the means by which local producers obtained and developed the technological capacity to produce medicines, and the types of product handled, among others.

The case studies complement other activities of WHO and ICTSD under this project, which include a stakeholder analysis, regional dialogues and a trends survey, with a view to identifying perceived obstacles to acquiring and developing technology, enabling local production and identifying means to overcoming these obstacles.

This series of case studies also complements UNCTAD’s ongoing work in the areas of technology transfer, investment and local pharmaceutical production. The case studies make an important contribution to a recommendation by UNCTAD’s Commission on Investment, Technology and Related Financial Issues. This recommendation states that UNCTAD should, within its work programme on investment, technology, transfer and intellectual property, assess ways in which developing countries can develop their domestic productive capability in the supply of essential drugs in cooperation with pharmaceutical companies.  By giving concrete examples of successful technology transfer initiatives in the area of pharmaceutical production, the case studies provide a number of important lessons for policy-makers and other stakeholders in both developing and developed countries on issues of investment, science, technology and innovation, and intellectual property rights.

Download '.pdf' Format of the Case Study.

Download Casestudies
Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024ISPE Singapore Affiliate Conference & Exhibition 2024Rehab Expo 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024